BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29741823)

  • 1. Comparative efficacy of four treatment regimens in Type 2 Leprosy Reactions (Prednisolone alone, Thalidomide alone, Prednisolone plus Thalidomide and Prednisolone plus Clofazimine).
    Kar HK; Gupta L
    Indian J Lepr; 2016 Jan; 88(1):29-38. PubMed ID: 29741823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide and steroid in the management of erythema nodosum leprosum.
    P K Mishra SR; Samal R; Behera B
    Indian J Pharmacol; 2022; 54(3):177-182. PubMed ID: 35848688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients.
    Hossain D
    Lepr Rev; 2013 Mar; 84(1):105-12. PubMed ID: 23741889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of clofazimine and pentoxifylline in type 2 lepra reaction: a double-blind, randomized, controlled study.
    Roy K; Sil A; Das NK; Bandyopadhyay D
    Int J Dermatol; 2015 Nov; 54(11):1325-32. PubMed ID: 26094723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide in leprosy--study of 94 cases.
    Parikh DA; Ganapati R; Revankar CR
    Indian J Lepr; 1986; 58(4):560-6. PubMed ID: 3572098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for erythema nodosum leprosum. A Cochrane review.
    Van Veen NH; Lockwood DN; Van Brakel WH; Ramirez J; Richardus JH
    Lepr Rev; 2009 Dec; 80(4):355-72. PubMed ID: 20306635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine.
    Ramu G; Girdhar A
    Lepr India; 1979 Oct; 51(4):497-504. PubMed ID: 522443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP; Malta AM; Sarno EN; Kaplan G
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open trial with clofazimine in the management of recurrent lepra reaction using thalidomide as a control drug.
    Iyer CG; Ramu G
    Lepr India; 1976 Oct; 48(4 Suppl):690-4. PubMed ID: 1026805
    [No Abstract]   [Full Text] [Related]  

  • 13. Experience with multidrug therapy in paucibacillary leprosy.
    Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
    Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M; Saunderson PR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with the combination of clofazimine (Lamprene) and long-term steroid therapy in the treatment of leprosy.
    Hogerzeil LM
    Lepr India; 1976 Oct; 48(4 Suppl):718-21. PubMed ID: 1026809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zafirlukast on leprosy reactions.
    Vides EA; Cabrera A; Ahern KP; Levis WR
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):71-5. PubMed ID: 10407633
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary oral tuberculosis in a patient with lepromatous leprosy: Diagnostic dilemma.
    Ganesan V; Mandal J
    Int J Mycobacteriol; 2016 Mar; 5(1):102-5. PubMed ID: 26927999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.